Online Pharmacy link
 
top2-3
Contact Us contactus Ελληνικά flag
top3-3
THE SOCIETY
NATIONAL CONGRESS
WORKING GROUPS SEMINARS
REGIONAL CONGRESSES OF THE HELLENIC CARDIOLOGICAL SOCIETY
SCIENTIFIC PROGRAMS
WORKING GROUPS-OLD STRUCTURE
WORKING GROUPS-NEW STRUCTURE
EDUCATION
HELLENIC JOURNAL OF CARDIOLOGY
CALENDAR
LINKS
INTERNATIONAL JOURNALS
PATIENT NEWS
WEBINARS
GUIDELINES
YOUNG CARDIOLOGISTS
ACTIONS OF THE HELLENIC CARDIOLOGICAL SOCIETY
NEWS FROM ESC
STUDIES
 
Clinical Issues
REVIEWS
Prevention
Imaging
Arterial Hypertention
Valvular Heart Disease
Thromboembolism Disease
Αrrhythmias
Coronary Artery Disease
Cardiomyopathies
Heart Failure
more>>
INTERVIEWS
Atrial Fibrillation
Myocardial Infarction. How much are we at risk?
more>>
 
ESC Guidelines
COMPENDIUM of Abridged ESC Guidelines 2010
European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary
Prevention of Cardiovascular Disease
Hypertension
more>>
Special Links
 
Special Releases
NEW PUBLICATIONS
more>>
 
challenge
Herodotos
HCS
Scientific Highlights
AHA/ACC/HEART RHYTHM SOCIETY RELEASE UPDATED AF MANAGEMENT GUIDELINE
The American Heart Association, American College of Cardiology and Heart Rhythm Society have released the 2014 Guideline for the Management of...
ACC 2014, 29-31 MARCH WASHINGTON
SYMPLICITY HTN-3 presented: Renal denervation misses primary efficacy endpoint The SYMPLICITY HTN-3 trial although was found safe, failed to show...
ΡANOLAZINE FOR THE TREATMENT OF REFRACTORY CHRONIC STABLE ANGINA PECTORIS AS DETERMINED FROM A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED CLINICAL TRIALS
Despite the use of traditional antianginal medication (beta-blockers, calcium channel blockers, and nitrates) and revascularization, symptoms of...
RANOLAZINE IS COST – EFFECTIVE IN PATIENTS WITH REFRACTORY ANGINA
I this study evaluated the cost- effectiveness of ranolazine when added to standard-of-care (SoC) antianginals in patients with stable coronary...
BETA BLOCKERS AND PERIOPERATIVE CARE: EUROPEAN HEART JOURNAL EDITORIAL ADDRESSES CONTROVERSY
Since the end of 2011 when the scientific work of Professor Don Poldermans was first scrutinized there has been controversy in the medical world...
NEW GUIDELINES OUTLINE STROKE RISKS UNIQUE TO WOMEN
A new set of guidelines on the prevention of stroke in women calls for the development of a female-specific stroke risk score and recommends...
GUIDELINES ISSUED FOR DIAGNOSIS, TREATMENT OF HF IN CHILDREN
The Canadian Cardiovascular Society has issued guidelines on the presentation, diagnosis and medical management of HF in children. Can J...
EVOLOCUMAB MEETS PRIMARY EFFICACY ENDPOINTS IN PHASE 3 STUDY
Evolocumab, a PCSK9 inhibitor, showed favorable results from a phase 3 trial assessing its efficacy as a cholesterol-lowering therapy in...
CHMP: NO TO SERELAXIN (REASANZ), YES TO RIOCIGUAT (ADEMPAS)
The European Medicines Agency (EMA) 's Committee for Medicinal Products for Human Use (CHMP) made two decisions this week on cardio-related...
SYMPLICITY HTN-3 FAILS TO MEET PRIMARY EFFICACY ENDPOINT
Medtronic has announced today that the SYMPLICITY HTN-3 trial, the pivotal study evaluating the company’s Symplicity renal denervation...
AHA ISSUES NEW RECOMMENDATIONS FOR THROMBOSIS IN PEDIATRIC AND CONGENITAL HEART DISEASE
The American Heart Association has issued a scientific statement on the prevention and treatment of thrombosis in children and adults with...
AHA: GENETIC TESTING FOR CVD EXPECTED IN ‘NEAR FUTURE’
Genetic susceptibility testing for the prevention and treatment of CVD is expected to be possible for individuals, families and populations in...
SOCIETIES UPDATE APPROPRIATE DIAGNOSTIC PROCEDURES FOR STABLE ISCHEMIC HEART DISEASE
The American College of Cardiology Foundation Appropriate Use Criteria Task Force recently led an appropriate use review of stress testing and...
NEW GUIDELINE FOR MANAGEMENT OF HIGH BP IN ADULTS RELEASED
A new guideline for the management of high BP in adults, developed by the Eighth Joint National Committee and containing nine recommendations and a...
ESC 2014, BARCELONA
FDA PANEL VOTED IN FAVOR OF WATCHMAN DEVICE FOR STROKE PREVENTION
The FDA’s Circulatory System Devices Panel voted 13-1 that the benefits of a left atrial appendage closure technology for the prevention of...
THE WAIT IS OVER: THE NEW CHOLESTEROL TREATMENT GUIDELINES ARE HERE
After a long wait the new 2013 American College of Cardiology/American Heart Association Cholesterol Treatment Guidelines are here. The 2013...
THE NEW OBESITY AND LIFESTYLE GUIDELINES
As clinicians, we are not as aggressive at counseling our overweight and obese patients about diet, exercise and weight loss during the upcoming...
CONSENSUS STATEMENT OUTLINES USE OF INTRACORONARY DIAGNOSTIC TOOLS
The Society for Cardiovascular Angiography and Interventions has published an expert consensus document that provides a set of recommendations to...
FIRST-IN-CLASS MitraClip RECEIVES FDA APPROVAL
Abbott Vascular has announced today that its first-in-class, catheter-based MitraClip device has been approved by the FDA for the treatment of...
more>>
Case Reports
 
GIANT CARDIAC HYDATID CYST WITH RARE ADHESIONS We present a 29-year-old woman admitted... QUADRICUSPID PULMONARY VALVE IN AN ADULT PATIENT We describe a case of quadricuspid pulmonary...
 
more>>
Hot Articles
VITAMIN D SUPPLEMENTATION HAS NO EFFECT ON CV, CANCER OR SKELETAL OUTCOMES Vitamin D supplementation does not appear to prevent MI, stroke, cancer or bone fractures and results of future trials are unlikely to yield different conclusions, according to a series of...
HERPES ZOSTER INCREASED RISK FOR STROKE, TIA, MI IN YOUNG PEOPLE Herpes zoster is an independent risk factor for stroke, transient ischemic attack and MI in people whose cases occurred when they were younger than 40 years, according to recent study...
WARFARIN INITIATION INCREASED STROKE RISK WITHIN 30 DAYS OF USE Patients with atrial fibrillation have nearly double the risk for stroke in the first 30 days after warfarin initiation compared with nonusers. Eur Heart J. ...
FIBRINOLYTIC AGENT PLUS URGENT PCI REDUCED MORTALITY IN OLDER STEMI PATIENTS A strategy involving a reduced dose of fibrinolytic agents plus urgent PCI was associated with improved survival at 30 days compared with primary PCI in a cohort of older patients with STEMI Am...
STUDY SHOWS VALUE OF CAC SCREENING FOR PREDICTION OF CV EVENTS Coronary artery calcium may help risk stratify asymptomatic individuals at the extremes of risk factor burden. Eur Heart J. ...
MIPOMERSEN REDUCED ARTHEROSCLEROTIC LIPOPROTEINS IN FAMILIAL HYPERCHOLESTEROLEMIA Mipomersen effectively and safely reduced all atherosclerotic lipoproteins associated with familial hypercholesterolemia for a sustained time period, according to recently published data. Eur...
RE-COVER II: DABIGATRAN MET 6-MONTH PRIMARY ENDPOINT FOR TREATMENT OF DVT, PE New 6-month data from the phase 3 RE-COVER II study demonstrate that dabigatran met the primary endpoint of noninferiority to warfarin for recurrent, symptomatic, objectively confirmed deep vein...
MORPHINE MAY DECREASE CLOPIDOGREL CONCENTRATIONS, EFFECTS Researchers have identified a novel drug-drug interaction between morphine and clopidogrel. According to new data published in healthy adults who received clopidogrel and morphine, morphine was...
'OBESITY PARADOX' IDENTIFIED IN ACUTE DECOMPENSATED HF Obesity is associated with incident heart failure (HF), but is paradoxically associated with better prognosis during chronic HF. This meta analysis showed that lower BMI in acutely...
HIGH-DOSE STATINS PRIOR TO PCI FOR NSTE-ACS DECREASE CV EVENTS Administering high-dose statins prior to PCI in patients with non-ST segment elevation ACS reduces periprocedural MI and short-term clinical events, results of a meta-analysis indicate. Catheter...
THYROID SCREENING INFREQUENT IN NEWLY DIAGNOSED HYPERLIPIDEMIA Only about 50% of patients with newly diagnosed hyperlipidemia were screened for hypothyroidism, despite current recommendations to screen for the condition prior to starting lipid-lowering...
WARFARIN REINITIATION AFTER MAJOR GI BLEEDING IMPROVED SURVIVAL Patients with atrial fibrillation who restarted anticoagulation therapy shortly after a major gastrointestinal bleeding episode had improved survival and reduced thromboembolism risk without...
more>>
HCS NEWS
Cardiology Update 2015 21st International Postgraduate Course on Cardiovascular Disease
April 8 2014
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
March 25 2014
Volume: 15 / Number: 4 / Publication Date: March 2014 / Owner: European Society of Cardiology
U.E.M.S. Cardiology Section
February 13 2014
Dear delegates to UEMS Cardiology Section, this is to notify you that the European Society of Cardiology (ESC) and UEMS Cardiology Section (CS),...
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
January 28 2014
Volume: 15 / Number: 2 / Publication Date: February 2014 / Publisher: European Society of Cardiology
REGISTRATION AT HEART FAILURE 2014 IN ATHENS
January 21 2014
Τhe HFA Board has designed special prices for the Greek participants: -Free for Local Medical Students -200€ for local...
INNOVATION IN EDUCATION AT WORK
January 20 2014
For more information please click here.
SURGERY IN SEVERE MITRAL REGURGITATION: FOCUS ON PATIENTS WITH NO SYMPTOMS OR COMPLICATIONS
An article from the e-journal of the ESC Council for Cardiology Practice Mitral valve repair is often recommended in severe mitral regurgitation...
HEART FAILURE 2014 ABSTRACT SUBMISSION
Abstract submission deadline: 21 January 2014. For more information please click here.
PRESS RELEASE ABOUT SYMPLICITY HTN-3
In light of Medtronic’s announcement of Thursday, 9th January 2014, about SYMPLICITY HTN-3, the Resistant Hypertension Course Scientific...
New insights regarding management of diabetes
Cardiologists are frontline specialists when it comes to preventing diabetes and cardiovascular disease. We especially cannot escape managing...
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
Volume: 15 / Number: 1 / Publication Date: January 2014 / Publisher: European Society of Cardiology
EUROINTERVENTION-OFFICIAL JOURNAL OF EUROPCR
Volume 9/Number 8 - December 2013
EUROPEAN HEART JOURNAL CARDIOVASCULAR IMAGING
Volume: 14 / Number: 12 / Publication Date: December 2013 / Publisher: European Society of Cardiology
HEART FAILURE 2014-GET INVOLVED!
For more info please click here.
NATIONAL CONGRESS OF BULGARIAN SOCIETY OF CARDIOLOGY
VARNA, GOLDEN SANDS RESORT For more information please click here.
CHALLENGE DATABASE NEWS
Each year approximately 1.000 children are born in Greece with a congenital heart defect. To read more please click here.
YOUNG CARDIOLOGISTS
During the 34th Panhellenic Cardiology Congress, Young Cardiologists will have the opportunity to take part in interesting discussions and lectures...
DON'T MISS IT!
Top reasons for cardiovascular professionals not to miss Best of ESC Congress 2013 on Thursday 12 September For more info please click here.
ESC CONGRESS 365
Your free access to ESC Congress content all year long. Please follow this link to view thousands of webcasts, slides, abstracts and reports from...
BEST OF ESC 2013
Don't miss the Best of ESC Congress online event ...
more >>
cardiomap

 
 
6 Potamianou 11528 Athens
Phone: +30 210 722 1633, 210 725 8003-8
Fax: +30 210 722 6139
 
facebook    twitter
 
    Sponsors
Powered: By Inspirit Graphics Studio